These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25227911)

  • 1. Prompt all-trans retinoic acid administration and early death in acute promyelocytic leukemia: what does the evidence say?
    Rashidi A; Fisher SI
    Leukemia; 2014 Dec; 28(12):2425-6. PubMed ID: 25227911
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid.
    Autore F; Chiusolo P; Sorà F; Giammarco S; Laurenti L; Innocenti I; Metafuni E; Piccirillo N; Pagano L; Bacigalupo A; Leone G; Sica S
    Leuk Lymphoma; 2019 May; 60(5):1328-1330. PubMed ID: 30526180
    [No Abstract]   [Full Text] [Related]  

  • 3. The "retinoic acid syndrome" in acute promyelocytic leukemia.
    Frankel SR; Eardley A; Lauwers G; Weiss M; Warrell RP
    Ann Intern Med; 1992 Aug; 117(4):292-6. PubMed ID: 1637024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. All-trans retinoic acid for acute promyelocytic leukemia. Results of the New York Study.
    Frankel SR; Eardley A; Heller G; Berman E; Miller WH; Dmitrovsky E; Warrell RP
    Ann Intern Med; 1994 Feb; 120(4):278-86. PubMed ID: 8291820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of all-trans-retinoic acid metabolism by fluconazole in vitro and in patients with acute promyelocytic leukemia.
    Schwartz EL; Hallam S; Gallagher RE; Wiernik PH
    Biochem Pharmacol; 1995 Sep; 50(7):923-8. PubMed ID: 7575674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-Bromopalmitate targets retinoic acid receptor alpha and overcomes all-trans retinoic acid resistance of acute promyelocytic leukemia.
    Lu Y; Yan JS; Xia L; Qin K; Yin QQ; Xu HT; Gao MQ; Qu XN; Sun YT; Chen GQ
    Haematologica; 2019 Jan; 104(1):102-112. PubMed ID: 30076181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group.
    Adès L; Thomas X; Bresler AG; Raffoux E; Spertini O; Vey N; Marchand T; Récher C; Pigneux A; Girault S; Deconinck E; Gardin C; Tournilhac O; Lambert JF; Chevallier P; de Botton S; Lejeune J; Dombret H; Chevret S; Fenaux P
    Haematologica; 2018 Dec; 103(12):2033-2039. PubMed ID: 30026341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of a Real-Life Population of Patients With Acute Promyelocytic Leukemia Treated According to the PETHEMA Guidelines: The Polish Adult Leukemia Group (PALG) Experience.
    Sobas M; Czyż A; Montesinos P; Armatys A; Helbig G; Hołowiecka A; Pluta A; Zarzycka E; Piątkowska-Jakubas B; Majcherek M; Lewandowski K; Gołos A; Paluszewska M; Podhorecka M; Oleksiuk J; Skręt A; Hawrylecka D; Guzicka-Kazimierczak RE; Wątek M; Gromek T; Charliński G; Grosicki S; Holojda J; Miśkiewicz W; Martinez-Cuadrón D; Sanz MA; Wróbel T; Wierzbowska A; Giebel S
    Clin Lymphoma Myeloma Leuk; 2020 Feb; 20(2):105-113. PubMed ID: 31874794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two successful deliveries of healthy children by a young woman diagnosed and treated during induction and relapsed therapy for acute promyelocytic leukemia.
    Dang CC; Guan YK; Lau NS; Chan SY
    J Oncol Pharm Pract; 2020 Dec; 26(8):2034-2037. PubMed ID: 32279594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combination of UCN-01 and ATRA triggers differentiation in ATRA resistant acute promyelocytic leukemia cell lines via RAF-1 independent activation of MEK/ERK.
    Liang C; Ding M; Weng XQ; Sheng Y; Wu J; Cai X
    Food Chem Toxicol; 2019 Apr; 126():303-312. PubMed ID: 30840849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute Promyelocytic Leukemia in Children: A Model of Precision Medicine and Chemotherapy-Free Therapy.
    Gurnari C; Voso MT; Girardi K; Mastronuzzi A; Strocchio L
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33440683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic evaluation of arsenic trioxide compared to all-trans retinoic acid + conventional chemotherapy for treatment of relapsed acute promyelocytic leukemia in Canada.
    Lachaine J; Mathurin K; Barakat S; Couban S
    Eur J Haematol; 2015 Sep; 95(3):218-29. PubMed ID: 25354894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Four years' experience with the treatment of all-trans retinoic acid in acute promyelocytic leukemia.
    Wu X; Wang X; Qien X; Liu H; Ying J; Yang Z; Yao H
    Am J Hematol; 1993 Jul; 43(3):183-9. PubMed ID: 8352233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRAM-1 is a novel adaptor protein regulated by retinoic acid (RA) and promyelocytic leukemia (PML)-RA receptor alpha in acute promyelocytic leukemia cells.
    Moog-Lutz C; Peterson EJ; Lutz PG; Eliason S; Cavé-Riant F; Singer A; Di Gioia Y; Dmowski S; Kamens J; Cayre YE; Koretzky G
    J Biol Chem; 2001 Jun; 276(25):22375-81. PubMed ID: 11301322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid.
    Park JH; Qiao B; Panageas KS; Schymura MJ; Jurcic JG; Rosenblat TL; Altman JK; Douer D; Rowe JM; Tallman MS
    Blood; 2011 Aug; 118(5):1248-54. PubMed ID: 21653939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for early in-hospital death in patients who developed coagulopathy during induction therapy for acute promyelocytic leukemia: a nationwide analysis in Japan.
    Matsuda K; Jo T; Toyama K; Nakazaki K; Matsui H; Fushimi K; Yasunaga H; Kurokawa M
    Ann Hematol; 2021 Oct; 100(10):2613-2619. PubMed ID: 34308494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. All-trans retinoic acid for the treatment of acute promyelocytic leukemia in pregnancy.
    Incerpi MH; Miller DA; Posen R; Byrne JD
    Obstet Gynecol; 1997 May; 89(5 Pt 2):826-8. PubMed ID: 9166337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. All-trans-retinoic acid in acute promyelocytic leukemia.
    Tallman MS; Andersen JW; Schiffer CA; Appelbaum FR; Feusner JH; Ogden A; Shepherd L; Willman C; Bloomfield CD; Rowe JM; Wiernik PH
    N Engl J Med; 1997 Oct; 337(15):1021-8. PubMed ID: 9321529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of combination therapy with all-trans retinoic acid and arsenic trioxide on acute promyelocytic leukemia].
    Zhang GC; Zheng D; Li QH; Luo SK; Li J; Peng AH; Tong XZ; Tan EX; Hong WD
    Ai Zheng; 2004 Apr; 23(4):430-4. PubMed ID: 15087033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute promyelocytic leukemia in pregnancy: all-trans retinoic acid as a newer therapeutic option.
    Celo JS; Kim HC; Houlihan C; Canavan BF; Manzullo GP; Saidi P
    Obstet Gynecol; 1994 May; 83(5 Pt 2):808-11. PubMed ID: 8159357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.